Advertisement Sorin Group launches new defibrillation leads in Japan - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sorin Group launches new defibrillation leads in Japan

Sorin Group has announced the Japanese approval and the market release of Isoline, its latest generation of defibrillation leads. Isoline defibrillation leads are now available worldwide, the company said.

Isoline leads are steroid eluting, dual coil defibrillation leads available in two fixation and two lengths models. With a fully isodiametric 7.8F lead body, Isoline leads include Easyturn: a quick lead placement system for positioning the lead and extending the helix with a single stylet, and Easy Mapping to obtain pacing thresholds without helix extension, said Sorin Group.

Fred Hrkac, president of Sorin Group’s cardiac rhythm management business unit, said: “Isoline leads and other cardiac rhythm management devices are distributed in Japan by Japan Lifeline (JLL), a leading distributor of medical devices based in Tokyo. Sorin Group signed a 10-year partnership agreement with JLL in 2007. The approval of Isoline ensures JLL can now distribute a complete Sorin Group ICD system, composed of Ovatio ICD family and Isoline defibrillation leads.”